ETFMG TREATMENTS TESTING AND ADVANCEMENTS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.9 USD | +2.61% |
|
+3.40% | 0.00% |
| Current month | -8.20% | ||
| 1 month | -6.26% |
Investment objective
The Fund's investment objective seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| - RUB | - | - | - | -.--% | ||
| 0.214 EUR | -.--% | - | - | -.--% | ||
| - EUR | -.--% | - | - | -.--% | ||
| - GBX | -.--% | - | - | -.--% | ||
| - AUD | -.--% | - | - | -.--% | ||
| - USD | -.--% | - | - | -.--% | ||
| - AUD | -.--% | - | - | -.--% | ||
| - EUR | -.--% | - | - | -.--% | ||
| - NOK | -.--% | - | - | -.--% | ||
| 0.3938 CAD | -17.11% | - | - | -.--% | ||
| 21.1 CAD | -0.24% | - | - | -.--% | ||
| 108 USD | +1.69% | +6.47% | +8.57% | 6.69% | ||
| 143.3 USD | -0.28% | -0.76% | -25.13% | 6.12% | ||
| 198.4 USD | +0.03% | -1.53% | -12.71% | 5.51% | ||
| 134.3 USD | -0.86% | +4.53% | -2.63% | 5.28% | ||
| 7.35 USD | +43.84% | +39.47% | +46.41% | 4.97% | ||
| 60.72 USD | +1.10% | -0.18% | -3.31% | 4.29% | ||
| 39.64 USD | -0.13% | +1.33% | -46.21% | 3.83% | ||
| 275.9 USD | +0.12% | -1.35% | -14.54% | 3.73% | ||
| 11.21 USD | +0.36% | -5.00% | -19.81% | 3.60% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 16.9 | +2.61% | 2,830 |
| 25/04/24 | 16.47 | -1.26% | 598 |
| 24/04/24 | 16.68 | -1.30% | 1,041 |
| 23/04/24 | 16.9 | +1.59% | 522 |
| 22/04/24 | 16.64 | +1.78% | 2,910 |
Other stock markets
Delayed Quote Nyse
Last update April 26, 2024 at 09:10 pm
More quotesDescription
| US26924G7631 | |
|---|---|
| Total Expense Ratio |
- Stock Market
- ETF
- GERM ETF
